Datis Pars Company visits Dakpha Pharmaceutical Group factories

Dakpha Pharmaceutical Group started its activity in 2010 with the help of a group of university and industry experts. Subsidiaries of this group produce specialized anti-cancer products, Hazard, opium derivatives, narcotics, anti-diabetes and specific disease drugs. The factories of this group, in order to provide the latest achievements in the field of production, quality control and performance, are ready to visit and provide capabilities and services to the applicant companies.

The technical team of Datis Pars Company visited Baran and Alborz Pharmed chemical and pharmaceutical companies on June 7, 1400.

In this program, first, different parts of the production site of Baran chemical and pharmaceutical factory, located in Eshtehard industrial town, were visited; Then, the esteemed visiting delegation examined the different parts of Alborz Pharmed Company. In addition, while presenting a comprehensive report on the most up-to-date products and facilities of three chemical and pharmaceutical companies, Baran, Alborz Pharmed and Danesh Pharmaceutical Development, esteemed members of the visiting board and CEO of Alborz Pharmed Company, Mr. Moradi and CEO of Baran Company, Mr. Dr. Saremi exchanged views and information.

Subsidiaries

advanced divider

Social media

advanced divider

Last News